ELISA News and Research

RSS

Tumor-derived GDF-15 suppresses immunotherapy response

Researchers evaluate the impact of tumor-derived GDF-15 on responses to anti-PD-1 immunotherapy.

26 Jul 2023

Characterizing the concentration and binding affinity of WT–induced antibodies against the Omicron subvariant BA.1

A recent study characterized the concentration and binding affinity of antibodies induced by SARS-CoV-2 WT strain against the Omicron subvariant BA.1.

25 Jul 2023

New brain-penetrant agonist shows promise in protecting dopamine neurons for Parkinson's disease treatment

Researchers reported on Nurr1 as a promising therapeutic target for managing Parkinson's disease (PD).

20 Jul 2023

Pro-inflammatory cytokine levels and their relation to preeclampsia severity

Researchers examine plasma interleukin-6, vascular cell adhesion molecule-1, and C-reactive protein levels in pregnant women with preeclampsia.

20 Jul 2023

Study reveals potential target for repairing beta-cell dysfunction in Type 2 diabetes

Researchers used a murine model to demonstrate that functional excision of murine PITPNA eventually led to hyperglycemia in mice.

19 Jul 2023

Study identifies potential immune biomarker for pulmonary tuberculosis: a step towards early detection

Researchers have identified a potential immune biomarker associated with pulmonary TB in active patients compared to controls.

19 Jul 2023

The immunogenicity and safety of poxvirus-based Nipah vaccines that can be used in humans and species

Researchers characterized the immunogenicity and safety of poxvirus-based Nipah vaccines that can be used in humans and species.

19 Jul 2023

Are antidrug antibodies reducing the effectiveness of rheumatoid arthritis treatment?

Researchers examined the association between antidrug antibodies and the response to treatments for rheumatoid arthritis.

17 Jul 2023

The prognostic value of PCSK9 levels for predicting major adverse cardiovascular events and mortality in diabetics

Researchers investigate the prognostic value of PCSK9 levels in diabetes patients to predict all-cause mortality and major adverse cardiovascular events.

17 Jul 2023

Boosted immunity: Delta and Omicron-BA.1 infections enhance protection in vaccinated patients

Researchers examined the immune response and potential cross-protection in hospitalized patients with breakthrough infections.

17 Jul 2023

Exploring the relationship between epigenetic aging and gut microbiome composition in physically fit men and women

Researchers investigate the relationship between the gut microbiome, physical fitness, and epigenetic aging in physically fit individuals.

14 Jul 2023

IL-9 identified as contributor to viral spread and airway inflammation in COVID-19

Researchers used a K18-hACE2 transgenic (ACE2.Tg) mouse model to demonstrate that interleukin-9 (IL-9).

13 Jul 2023

mAb-based bELISA developed to detect SARS-CoV-2 antibodies in a broad spectrum of animal species

Researchers developed a mAb-based blocking enzyme-linked immunosorbent assay (bELISA) to detect SARS-CoV-2 in animals.

11 Jul 2023

Novel vaccine against Lyme disease reported to be safe and effective

Researchers determine the safety and immunogenicity of a novel candidate vaccine against Lyme borreliosis.

11 Jul 2023

Prolonged T-cell response during severe COVID-19 does not contribute to long COVID

Persistent immune activation and elevated cytokine levels were observed in patients with severe COVID-19, even months after recovery. However, the correlation between immune activation and long COVID symptoms appeared to be independent, suggesting other factors influencing disease severity.

9 Jul 2023

ELISA News and Research

Tumor-derived GDF-15 suppresses immunotherapy response

Characterizing the concentration and binding affinity of WT–induced antibodies against the Omicron subvariant BA.1

New brain-penetrant agonist shows promise in protecting dopamine neurons for Parkinson's disease treatment

Pro-inflammatory cytokine levels and their relation to preeclampsia severity

Study reveals potential target for repairing beta-cell dysfunction in Type 2 diabetes

Study identifies potential immune biomarker for pulmonary tuberculosis: a step towards early detection

The immunogenicity and safety of poxvirus-based Nipah vaccines that can be used in humans and species

Are antidrug antibodies reducing the effectiveness of rheumatoid arthritis treatment?

The prognostic value of PCSK9 levels for predicting major adverse cardiovascular events and mortality in diabetics

Boosted immunity: Delta and Omicron-BA.1 infections enhance protection in vaccinated patients

Exploring the relationship between epigenetic aging and gut microbiome composition in physically fit men and women

IL-9 identified as contributor to viral spread and airway inflammation in COVID-19

mAb-based bELISA developed to detect SARS-CoV-2 antibodies in a broad spectrum of animal species

Novel vaccine against Lyme disease reported to be safe and effective

Prolonged T-cell response during severe COVID-19 does not contribute to long COVID

Scientists develop cross-species coronavirus test

Unlocking the immune puzzle: study evaluates the immune impact of second booster COVID-19 vaccine

Rising incidence of kiwifruit allergy in children: study highlights severe allergic reactions

A novel RSV vaccine that could be effective across all ages

Resistance training could be a simple and affordable therapy for Alzheimer's patients

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News